nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PTGS2—Triamcinolone—multiple sclerosis	0.354	0.424	CbGbCtD
Balsalazide—PTGS2—Betamethasone—multiple sclerosis	0.304	0.364	CbGbCtD
Balsalazide—PTGS2—Dexamethasone—multiple sclerosis	0.177	0.212	CbGbCtD
Balsalazide—Olsalazine—IFNG—multiple sclerosis	0.0109	1	CrCbGaD
Balsalazide—PPARG—leg—multiple sclerosis	0.00714	0.317	CbGeAlD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	0.00574	0.0489	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00503	0.0429	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00503	0.0429	CbGpPWpGaD
Balsalazide—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	0.00419	0.0357	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	0.0037	0.0315	CbGpPWpGaD
Balsalazide—PTGS2—leg—multiple sclerosis	0.00365	0.162	CbGeAlD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	0.00319	0.0272	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	0.00271	0.0231	CbGpPWpGaD
Balsalazide—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00241	0.159	CbGdCrCtD
Balsalazide—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00238	0.156	CbGdCrCtD
Balsalazide—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00238	0.156	CbGdCrCtD
Balsalazide—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00232	0.153	CbGdCrCtD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.0022	0.0187	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors—PGR—multiple sclerosis	0.00216	0.0184	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	0.00206	0.0175	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00204	0.0174	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00185	0.0158	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00181	0.0155	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00181	0.0155	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.0017	0.0145	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00165	0.014	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.00151	0.0129	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	0.00151	0.0129	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptors—VDR—multiple sclerosis	0.00151	0.0128	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00147	0.0125	CbGpPWpGaD
Balsalazide—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00146	0.0958	CbGdCrCtD
Balsalazide—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00143	0.0942	CbGdCrCtD
Balsalazide—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00143	0.0942	CbGdCrCtD
Balsalazide—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.0014	0.0921	CbGdCrCtD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.00122	0.0104	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00119	0.0101	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.00118	0.01	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—TNFRSF1A—multiple sclerosis	0.00117	0.01	CbGpPWpGaD
Balsalazide—ALOX5—nervous system—multiple sclerosis	0.00116	0.0515	CbGeAlD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.00114	0.00976	CbGpPWpGaD
Balsalazide—ALOX5—central nervous system—multiple sclerosis	0.00112	0.0496	CbGeAlD
Balsalazide—ALOX5—cerebellum—multiple sclerosis	0.00109	0.0485	CbGeAlD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.00105	0.00894	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CD24—multiple sclerosis	0.00103	0.00878	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	0.00101	0.00862	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	0.000984	0.00839	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000975	0.00831	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000964	0.00821	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000964	0.00821	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000935	0.00796	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	0.000902	0.00769	CbGpPWpGaD
Balsalazide—ALOX5—brain—multiple sclerosis	0.000888	0.0394	CbGeAlD
Balsalazide—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	0.000879	0.0075	CbGpPWpGaD
Balsalazide—PPARG—nervous system—multiple sclerosis	0.000872	0.0387	CbGeAlD
Balsalazide—PPARG—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.000864	0.00736	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000854	0.00727	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000854	0.00727	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.000841	0.00717	CbGpPWpGaD
Balsalazide—PPARG—central nervous system—multiple sclerosis	0.000839	0.0372	CbGeAlD
Balsalazide—ALOX5—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000836	0.00713	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000809	0.0069	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000779	0.00664	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000756	0.00644	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000711	0.00606	CbGpPWpGaD
Balsalazide—PPARG—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000697	0.00594	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000692	0.0059	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.00068	0.0058	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	0.000667	0.00568	CbGpPWpGaD
Balsalazide—PPARG—brain—multiple sclerosis	0.000666	0.0296	CbGeAlD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.000654	0.00558	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.000636	0.00542	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000634	0.00541	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000615	0.00524	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	0.000595	0.00507	CbGpPWpGaD
Balsalazide—PTGS2—medulla oblongata—multiple sclerosis	0.000593	0.0263	CbGeAlD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.000583	0.00497	CbGpPWpGaD
Balsalazide—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	0.000567	0.00483	CbGpPWpGaD
Balsalazide—PTGS1—spinal cord—multiple sclerosis	0.000553	0.0245	CbGeAlD
Balsalazide—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000549	0.00468	CbGpPWpGaD
Balsalazide—PTGS2—midbrain—multiple sclerosis	0.000542	0.024	CbGeAlD
Balsalazide—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	0.00054	0.0046	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—SRM—multiple sclerosis	0.00054	0.0046	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000533	0.00454	CbGpPWpGaD
Balsalazide—PTGS2—spinal cord—multiple sclerosis	0.000529	0.0234	CbGeAlD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	0.000529	0.00451	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000528	0.0045	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000528	0.0045	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—FAS—multiple sclerosis	0.000491	0.00419	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ZNF746—multiple sclerosis	0.00047	0.004	CbGpPWpGaD
Balsalazide—PTGS1—nervous system—multiple sclerosis	0.000466	0.0207	CbGeAlD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—MYC—multiple sclerosis	0.000466	0.00397	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000462	0.00394	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00046	0.00392	CbGpPWpGaD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—MAPK1—multiple sclerosis	0.000456	0.00388	CbGpPWpGaD
Balsalazide—PTGS1—central nervous system—multiple sclerosis	0.000449	0.0199	CbGeAlD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000448	0.00382	CbGpPWpGaD
Balsalazide—PTGS2—nervous system—multiple sclerosis	0.000445	0.0198	CbGeAlD
Balsalazide—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000436	0.00371	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—PTBP1—multiple sclerosis	0.000429	0.00366	CbGpPWpGaD
Balsalazide—PTGS2—central nervous system—multiple sclerosis	0.000429	0.019	CbGeAlD
Balsalazide—PTGS2—cerebellum—multiple sclerosis	0.000419	0.0186	CbGeAlD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000408	0.00348	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000405	0.00345	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.000395	0.00337	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000385	0.00328	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000384	0.00327	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP24A1—multiple sclerosis	0.00038	0.00324	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP27B1—multiple sclerosis	0.00038	0.00324	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000372	0.00317	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000371	0.00317	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00037	0.00315	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00037	0.00315	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000363	0.00309	CbGpPWpGaD
Balsalazide—PTGS1—brain—multiple sclerosis	0.000356	0.0158	CbGeAlD
Balsalazide—ALOX5—Metabolism—GPC5—multiple sclerosis	0.000348	0.00296	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.000347	0.00295	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000345	0.00294	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000342	0.00292	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000342	0.00291	CbGpPWpGaD
Balsalazide—PTGS2—brain—multiple sclerosis	0.000341	0.0151	CbGeAlD
Balsalazide—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.00034	0.0029	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000339	0.00289	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000338	0.00288	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—SRM—multiple sclerosis	0.000334	0.00285	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000325	0.00277	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—U2AF2—multiple sclerosis	0.000325	0.00277	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000322	0.00274	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	0.00032	0.00273	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000317	0.0027	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000308	0.00263	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000294	0.00251	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000294	0.0025	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000294	0.0025	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000292	0.00249	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—RRM1—multiple sclerosis	0.000288	0.00246	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000288	0.00245	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000286	0.00244	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.00028	0.00238	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000275	0.00234	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000268	0.00229	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000266	0.00227	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	0.000265	0.00226	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—PTPRC—multiple sclerosis	0.000264	0.00225	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	0.000257	0.00219	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	0.000254	0.00217	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000249	0.00212	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	0.000245	0.00209	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000245	0.00209	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—STAT3—multiple sclerosis	0.000241	0.00205	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP27B1—multiple sclerosis	0.000235	0.00201	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP24A1—multiple sclerosis	0.000235	0.00201	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000235	0.002	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—SRM—multiple sclerosis	0.000234	0.00199	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00023	0.00196	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	0.000228	0.00194	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000224	0.0019	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TGFB1—multiple sclerosis	0.000223	0.0019	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000218	0.00186	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—POMC—multiple sclerosis	0.000217	0.00185	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GPC5—multiple sclerosis	0.000215	0.00183	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TNF—multiple sclerosis	0.000208	0.00178	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000206	0.00175	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000201	0.00171	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.0002	0.0017	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—PABPC1—multiple sclerosis	0.0002	0.0017	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000194	0.00165	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000192	0.00164	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—SRM—multiple sclerosis	0.000186	0.00158	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—RPL5—multiple sclerosis	0.00018	0.00153	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—RRM1—multiple sclerosis	0.000178	0.00152	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	0.000177	0.0015	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000175	0.00149	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	0.000173	0.00147	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	0.000172	0.00147	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—IL6—multiple sclerosis	0.000168	0.00143	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—BCHE—multiple sclerosis	0.000165	0.00141	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP24A1—multiple sclerosis	0.000165	0.0014	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP27B1—multiple sclerosis	0.000165	0.0014	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	0.000163	0.00139	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000161	0.00137	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000161	0.00137	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000158	0.00135	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GPC5—multiple sclerosis	0.000151	0.00128	CbGpPWpGaD
Balsalazide—PTGS2—Disease—GPC5—multiple sclerosis	0.000143	0.00122	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—PGR—multiple sclerosis	0.000142	0.00121	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000138	0.00118	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	0.000134	0.00115	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000134	0.00114	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000132	0.00112	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP27B1—multiple sclerosis	0.000131	0.00112	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP24A1—multiple sclerosis	0.000131	0.00112	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000128	0.00109	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000128	0.00109	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	0.000125	0.00107	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—RRM1—multiple sclerosis	0.000125	0.00106	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GPC5—multiple sclerosis	0.00012	0.00102	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000119	0.00101	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	0.000119	0.00101	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TYK2—multiple sclerosis	0.000118	0.00101	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000108	0.000924	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—BCHE—multiple sclerosis	0.000102	0.000873	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	0.000101	0.000862	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—APOE—multiple sclerosis	9.95e-05	0.000848	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—RRM1—multiple sclerosis	9.92e-05	0.000845	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—VDR—multiple sclerosis	9.9e-05	0.000844	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.69e-05	0.000826	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP9—multiple sclerosis	9.31e-05	0.000794	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RPL5—multiple sclerosis	9.29e-05	0.000792	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.15e-05	0.00078	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.13e-05	0.000778	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.95e-05	0.000763	CbGpPWpGaD
Balsalazide—PTGS2—Disease—SLC11A1—multiple sclerosis	8.9e-05	0.000759	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—POMC—multiple sclerosis	8.55e-05	0.000729	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.52e-05	0.000726	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.33e-05	0.00071	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—STAT3—multiple sclerosis	8.28e-05	0.000706	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	8.17e-05	0.000697	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ALB—multiple sclerosis	7.8e-05	0.000664	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.69e-05	0.000656	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TGFB1—multiple sclerosis	7.67e-05	0.000654	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.59e-05	0.000647	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MAPK1—multiple sclerosis	7.53e-05	0.000641	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—BCHE—multiple sclerosis	7.17e-05	0.000612	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TNF—multiple sclerosis	7.17e-05	0.000611	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CD28—multiple sclerosis	7.11e-05	0.000606	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.61e-05	0.000563	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—APOE—multiple sclerosis	6.16e-05	0.000525	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.03e-05	0.000514	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—IL6—multiple sclerosis	5.78e-05	0.000493	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—BCHE—multiple sclerosis	5.7e-05	0.000485	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—POMC—multiple sclerosis	5.29e-05	0.000451	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CD86—multiple sclerosis	5.07e-05	0.000432	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ALB—multiple sclerosis	4.83e-05	0.000411	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CCR5—multiple sclerosis	4.5e-05	0.000383	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HLA-A—multiple sclerosis	4.38e-05	0.000374	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—APOE—multiple sclerosis	4.32e-05	0.000368	CbGpPWpGaD
Balsalazide—PTGS2—Disease—APOE—multiple sclerosis	4.09e-05	0.000349	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—MYC—multiple sclerosis	3.93e-05	0.000335	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—POMC—multiple sclerosis	3.71e-05	0.000316	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CD80—multiple sclerosis	3.7e-05	0.000315	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—APOE—multiple sclerosis	3.43e-05	0.000292	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ALB—multiple sclerosis	3.38e-05	0.000288	CbGpPWpGaD
Balsalazide—PTGS2—Disease—TYK2—multiple sclerosis	3.12e-05	0.000266	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—POMC—multiple sclerosis	2.94e-05	0.000251	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CD4—multiple sclerosis	2.82e-05	0.000241	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ALB—multiple sclerosis	2.68e-05	0.000229	CbGpPWpGaD
Balsalazide—PTGS2—Disease—STAT3—multiple sclerosis	2.19e-05	0.000186	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MYC—multiple sclerosis	2.03e-05	0.000173	CbGpPWpGaD
Balsalazide—PTGS2—Disease—TGFB1—multiple sclerosis	2.03e-05	0.000173	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MAPK1—multiple sclerosis	1.99e-05	0.000169	CbGpPWpGaD
Balsalazide—PTGS2—Disease—IL6—multiple sclerosis	1.53e-05	0.00013	CbGpPWpGaD
